Dow Jones

39 863,89

0,77%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
ARYA Sciences Acquisition Corporation IV (ARYD)
ARYA Sciences Acquisition Corporation IV (ARYD) Actualités

ARYD

ARYA Sciences Acquisitio... (ARYD)

ARYA Sciences Acquisition Corporation IV

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ARYD

Date	Heure	Source	Titre	Symbole	Société
06/05/2024	12h25	GlobeNewswire Inc.	Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
28/02/2024	23h25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
28/02/2024	23h02	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
26/02/2024	22h48	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
14/02/2024	22h15	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
14/02/2024	12h29	PR Newswire (US)	Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
01/02/2024	23h08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
22/01/2024	23h20	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
09/11/2023	22h30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
02/06/2023	22h32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
12/05/2023	22h32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
31/03/2023	22h33	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
27/02/2023	12h07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
14/02/2023	16h22	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
10/02/2023	22h46	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
31/01/2023	23h28	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
31/03/2022	15h02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
24/02/2022	13h18	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
24/02/2022	13h00	GlobeNewswire Inc.	ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
14/02/2022	16h30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
29/09/2021	23h13	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
29/09/2021	12h30	GlobeNewswire Inc.	Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
26/02/2021	02h04	GlobeNewswire Inc.	ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV